Search - tctmd.com

Displaying 321 - 340 of 447

Sort: Relevancy | Date

Presentation TVT 2013

Emerging Therapies for LAA Occlusion: The New Devices

Presenter: Jason Rogers

June 15, 2013

Presentation TVT 2013

Defining Nonvalvular A-fib: Not So Simple

Presenter: Michael Ezekowitz

June 15, 2013

Presentation TVT 2013

Complication of LAA Closure: Lariat (SentreHEART)

Presenter: Matthew Price

June 15, 2013

Presentation TVT 2013

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Presenter: Steven Yakubov

June 15, 2013

Presentation TVT 2013

Case Presentaton: Lariat (SentreHEART)

Presenter: Matthew Price

June 15, 2013

Presentation TVT 2013

Case Presentation: Wavecrest (Coherex Medical)

Presenter: Brian Whisenant

June 15, 2013

Presentation TVT 2013

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

Presenter: Saibal Kar

June 15, 2013

Presentation TVT 2013

"New" Anticoagulation Options for A-fib: Beyond Warfarin

Presenter: Michael Ezekowitz

June 15, 2013

Presentation TCT Russia 2013

LAA Closure Devices - Technique Description and Emerging Data

Presenter: Horst Sievert

June 09, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

Presentation

An Economic Evaluation of Percutaneous LAA Occlusion

Presenter: Sheldon M. Singh

June 04, 2013

Presentation

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Presenter: M. Urena

May 28, 2013

News Daily News

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

L.A. McKeown

May 28, 2013

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

Presentation

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

Presenter: Vivek Y. Reddy

May 14, 2013

Presentation Fellows 2013

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: Mark Reisman

April 17, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

News Daily News

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Yael L. Maxwell

April 12, 2013

Advertisement

Emerging Therapies for LAA Occlusion: The New Devices

Defining Nonvalvular A-fib: Not So Simple

Complication of LAA Closure: Lariat (SentreHEART)

Complex LAA Anatomy (Watchman Closure): Chicken Wing Morphology

Case Presentaton: Lariat (SentreHEART)

Case Presentation: Wavecrest (Coherex Medical)

Basic Echo Imaging of the LAA with Fluoroscopic Correlation

"New" Anticoagulation Options for A-fib: Beyond Warfarin

LAA Closure Devices - Technique Description and Emerging Data

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

An Economic Evaluation of Percutaneous LAA Occlusion

Percutaneous LAA Closure with the Amplatzer Cardiac Plug in Patients with Nonvalvular A-fib and Contraindications for Anticoagulation Therapy

Cardiac Plug Shows High Success, Low Complication Rate for LAA Closure

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

PROTECT AF: The Mortality Effects of LAA Closure vs. Warfarin for Stroke Prophylaxis in A-fib

LAA Closure for Nonvalvular Atrial Fibrillation

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content